91 related articles for article (PubMed ID: 16327307)
1. Interaction effect in bladder cancer between N-acetyltransferase 2 genotype and alcohol drinking.
Lu CM; Chung MC; Huang CH; Ko YC
Urol Int; 2005; 75(4):360-4. PubMed ID: 16327307
[TBL] [Abstract][Full Text] [Related]
2. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ
Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
Hao GY; Zhang WD; Chen YH; Zhang DX; Zhang YH
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):283-6. PubMed ID: 15312364
[TBL] [Abstract][Full Text] [Related]
5. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
Stern MC; Johnson LR; Bell DA; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690
[TBL] [Abstract][Full Text] [Related]
7. Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study.
Wang CY; Jones RF; Debiec-Rychter M; Soos G; Haas GP
Anticancer Res; 2002; 22(6B):3529-35. PubMed ID: 12552951
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between polymorphism of N-acetyltransferase 2 and genetic susceptibility to laryngeal carcinoma].
Lei D; Pan X; Guo C; Xu F; Zhang L; Liu D; Luan X
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):154-6. PubMed ID: 12015038
[TBL] [Abstract][Full Text] [Related]
9. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
Cascorbi I; Roots I; Brockmöller J
Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
[TBL] [Abstract][Full Text] [Related]
10. N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction.
Green J; Banks E; Berrington A; Darby S; Deo H; Newton R
Br J Cancer; 2000 Aug; 83(3):412-7. PubMed ID: 10917561
[TBL] [Abstract][Full Text] [Related]
11. A slow acetylator genotype associated with an increased risk of advanced cervical cancer.
Costa S; Medeiros R; Vasconcelos A; Pinto D; Lopes C
J Cancer Res Clin Oncol; 2002 Dec; 128(12):678-82. PubMed ID: 12474054
[TBL] [Abstract][Full Text] [Related]
12. GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study.
Zupa A; Sgambato A; Bianchino G; Improta G; Grieco V; LA Torre G; Campisi B; Traficante A; Aieta M; Cittadini A
Anticancer Res; 2009 May; 29(5):1709-14. PubMed ID: 19443391
[TBL] [Abstract][Full Text] [Related]
13. Genotypes of N-acetyltransferase-2 and risk of bladder cancer: a case-control study.
Filiadis IF; Georgiou I; Alamanos Y; Kranas V; Giannakopoulos X; Lolis D
J Urol; 1999 May; 161(5):1672-5. PubMed ID: 10210437
[TBL] [Abstract][Full Text] [Related]
14. The role of N-acetyltransferase-2 and glutathione S-transferase on the risk and aggressiveness of bladder cancer.
Giannakopoulos X; Charalabopoulos K; Baltogiannis D; Chatzikiriakidou A; Alamanos Y; Georgiou I; Evangelou A; Agnantis N; Sofikitis N
Anticancer Res; 2002; 22(6B):3801-4. PubMed ID: 12552997
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
[TBL] [Abstract][Full Text] [Related]
17. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors.
Schroeder JC; Conway K; Li Y; Mistry K; Bell DA; Taylor JA
Cancer Res; 2003 Nov; 63(21):7530-8. PubMed ID: 14612556
[TBL] [Abstract][Full Text] [Related]
19. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies.
Vineis P; Marinelli D; Autrup H; Brockmoller J; Cascorbi I; Daly AK; Golka K; Okkels H; Risch A; Rothman N; Sim E; Taioli E
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1249-52. PubMed ID: 11751441
[TBL] [Abstract][Full Text] [Related]
20. NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan.
Huang CC; Chien WP; Wong RH; Cheng YW; Chen MC; Chou MC; Lee H
Dis Colon Rectum; 2007 Jul; 50(7):981-9. PubMed ID: 17525862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
